Cypherpunk Technologies (STU:5MC) Loans Receivable: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:5MC Cypherpunk Technologies Inc STU:5MC
40 GF Score
Price €0.55
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Cypherpunk Technologies Loans Receivable?

Cypherpunk Technologies STU:5MC -1.44% 40 Loans Receivable is €0.00 Mil as of Jun. 2026. GuruFocus rates STU:5MC with a GF Score™ of 40/100 (Possible Value Trap). The stock has 3 warning signs investors should review.

Cypherpunk Technologies's Loans Receivable for the quarter that ended in Jun. 2026 was €0.00 Mil.

Cypherpunk Technologies Loans Receivable Related Terms

Cypherpunk Technologies Loans Receivable Historical Data

* Premium members only.

The historical data trend for Cypherpunk Technologies's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cypherpunk Technologies Loans Receivable Chart

Cypherpunk Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cypherpunk Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:5MC
40GF Score
Cypherpunk Technologies Inc STU:5MC
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cypherpunk Technologies Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.00 Mil mean?
Cypherpunk Technologies (STU:5MC) has a Loans Receivable of €0.00 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Cypherpunk Technologies and its competitors.
Is Cypherpunk Technologies' Loans Receivable too high?
Cypherpunk Technologies' current Loans Receivable is €0.00 Mil. Overall, Cypherpunk Technologies has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cypherpunk Technologies' Loans Receivable compare to VLT and GEG?
Cypherpunk Technologies' Loans Receivable of €0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for an Asset Management company?
A good Loans Receivable depends on the Asset Management industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Cypherpunk Technologies and its competitors. Cypherpunk Technologies's current Loans Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cypherpunk Technologies stock overvalued right now?
Based on GuruFocus' analysis, Cypherpunk Technologies (STU:5MC) is currently considered Possible Value Trap. The current Loans Receivable is €0.00 Mil. Cypherpunk Technologies' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Cypherpunk Technologies (STU:5MC), the current Loans Receivable is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cypherpunk Technologies Business Description

Other Exchanges CYPH:USA
Address 47 Thorndike Street, Suite B1-1, Cambridge, MA, USA, 02141
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
40GF Score

Get the complete analysis for STU:5MC

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.55
Price